The drug, which Novo Nordisk calls simply the Wegovy pill, uses the same active ingredient - semaglutide - that powers the original Wegovy, along with its sister drug for diabetes, Ozempic
Analysts project the GLP-1 obesity and diabetes market will reach somewhere between $100 billion and $200 billion by 2030, depending on pricing dynamics and oral formulation uptake
An umbrella review of 13 meta-analyses concluded that berberine did not significantly decrease body weight, BMI, or waist-to-hip ratio, though it had some lipid-lowering benefits
The main problem we can appreciate due to the bad conservation of the sewage system materializes when it cant provide the water coming from the rain and causes flooding in garages, offices and even in the streets
Even small increases in movement, like walking more and taking the stairs instead of the elevator, can make a difference over time
Therapeutic Advances in Drug Safety, 5 (5), 190